The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Impact of an immune modulator fingolimod on acute ischemic stroke
Open accessAbstract
Significance: In patients with acute ischemic stroke (AIS), the abrupt and massive influx of lymphocytes from the periphery to the ischemic region orchestrates focal inflammatory responses, catalyzes tissue death, and worsens clinical outcomes. In this early phase clinical study, we reduced lymphocyte migration to the brain during the first 72 h of AIS via oral administration of three doses of fingolimod. This administration led to a significant reduction of secondary lesion enlargement, microvascular permeability, and better clinical outcomes during the acute phase and 3-mo follow-up visit. This study will provoke new investigations on the efficacy of modulation of brain inflammation in AIS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., Larrue, V., Lees, K. R., Medeghri, Z., Machnig, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804656 · Cited by 6,684
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Kappos, L., Radue, E.-W., O'Connor, P., Polman, C., Hohlfeld, R., Calabresi, P., Selmaj, K., Agoropoulou, C., Leyk, M., Zhang-Auberson, L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909494 · Cited by 2,644
The immunology of stroke: from mechanisms to translation
Iadecola, C., & Anrather, J. (2011) · Nature Medicine · doi:10.1038/nm.2399 · Cited by 2,596 · cited 3×
“Excessive down-regulation of immunity by the brain itself is believed to be responsible for poststroke infection (7, 8).”
BackgroundLees, K. R., Bluhmki, E., von Kummer, R., Brott, T. G., Toni, D., Grotta, J. C., Albers, G. W., Kaste, M., Marler, J. R., Hamilton, S. A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60491-6 · Cited by 2,184
Eltzschig, H. K., & Carmeliet, P. (2011) · New England Journal of Medicine · doi:10.1056/nejmra0910283 · Cited by 2,061
Aoki, J., Kimura, K., Shibazaki, K., & Sakamoto, Y. (2013) · Cerebrovascular Diseases Extra · doi:10.1159/000348552 · Cited by 1,929
Stroke-Associated Pneumonia: Major Advances and Obstacles
Hannawi, Y., Hannawi, B., Rao, C. P. V., Suarez, J. I., & Bershad, E. M. (2013) · Cerebrovascular Diseases · doi:10.1159/000350199 · Cited by 1,656
'Malignant' Middle Cerebral Artery Territory Infarction: Clinical Course and Prognostic Signs
Hacke, W. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550040037012 · Cited by 1,352
Multiple Sclerosis: Current Knowledge and Future Outlook
Kamm, C. P., Uitdehaag, B. M., & Polman, C. H. (2014) · European Neurology · doi:10.1159/000360528 · Cited by 1,010
Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy
Moalem, G., Leibowitz–Amit, R., Yoles, E., Mor, F., Cohen, I. R., & Schwartz, M. (1999) · Nature Medicine · doi:10.1038/4734 · Cited by 889
Shichita, T., Sugiyama, Y., Ooboshi, H., Sugimori, H., Nakagawa, R., Takada, I., Iwaki, T., Okada, Y., Iida, M., Cua, D. J., et al. (2009) · Nature Medicine · doi:10.1038/nm.1999 · Cited by 842
Blood–Brain Barrier Breakdown in Acute and Chronic Cerebrovascular Disease
Yang, Y., & Rosenberg, G. A. (2011) · Stroke · doi:10.1161/strokeaha.110.608257 · Cited by 789
Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients
Schwab, S. R., Pereira, J. P., Matloubian, M., Xu, Y., Huang, Y., & Cyster, J. G. (2005) · Science · doi:10.1126/science.1113640 · Cited by 787
The immunology of acute stroke
Chamorro, Á., Meisel, A., Planas, A. M., Urra, X., van de Beek, D., & Veltkamp, R. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.98 · Cited by 707
Baird, A. E., Benfield, A., Schlaug, G., Siewert, B., Lövblad, K., Edelman, R. R., & Warach, S. (1997) · Annals of Neurology · doi:10.1002/ana.410410506 · Cited by 581
Liesz, A., Zhou, W., Mracskó, É., Karcher, S., Bauer, H., Schwarting, S., Sun, L., Bruder, D., Stegemann, S., Cerwenka, A., et al. (2011) · Brain · doi:10.1093/brain/awr008 · Cited by 411
Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis
Cohen, J. A., & Chun, J. (2011) · Annals of Neurology · doi:10.1002/ana.22426 · Cited by 393
Schwamm, L. H., Koroshetz, W. J., Sorensen, A. G., Wang, B., Copen, W. A., Budzik, R., Rordorf, G., Buonanno, F. S., Schaefer, P. W., & Gonzalez, R. G. (1998) · Stroke · doi:10.1161/01.str.29.11.2268 · Cited by 370
Kleinschnitz, C., Schwab, N., Kraft, P., Hagedorn, I., Dreykluft, A., Schwarz, T., Austinat, M., Nieswandt, B., Wiendl, H., & Stoll, G. (2010) · Blood · doi:10.1182/blood-2009-10-249078 · Cited by 358
Fingolimod for the Treatment of Intracerebral Hemorrhage: A 2-Arm Proof-of-Concept Study
Fu, Y., Hao, J., Zhang, N., Ren, L., Sun, N., Li, Y.-J., Yan, Y., Huang, D., Yu, C., & Shi, F.-D. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1065 · Cited by 278
Self-citationFingolimod provides long‐term protection in rodent models of cerebral ischemia
Wei, Y., Yemisci, M., Kim, H., Yung, L. M., Shin, H. K., Hwang, S., Guo, S., Qin, T., Alsharif, N., Brinkmann, V., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22186 · Cited by 277
Ischemic neurons recruit natural killer cells that accelerate brain infarction
Gan, Y., Liu, Q., Wu, W., Yin, J.-X., Bai, X.-F., Shen, R., Wang, Y., Chen, J., La Cava, A., Poursine-Laurent, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315943111 · Cited by 273
Self-citationFirst Human Trial of FTY720, a Novel Immunomodulator, in Stable Renal Transplant Patients
Budde, K., Schmouder, R. L., Brunkhorst, R., Nashan, B., Lu[Combining Diaeresis]cker, P. W., Mayer, T., Choudhury, S., Skerjanec, A., Kraus, G., & Neumayer, H. H. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1341073 · Cited by 270
Hasegawa, Y., Suzuki, H., Sozen, T., Rolland, W., & Zhang, J. H. (2010) · Stroke · doi:10.1161/strokeaha.109.568899 · Cited by 242
Endres, M. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600116 · Cited by 200
Kraft, P., Göb, E., Schuhmann, M. K., Göbel, K., Deppermann, C., Thielmann, I., Herrmann, A. M., Lorenz, K., Brede, M., Stoll, G., et al. (2013) · Stroke · doi:10.1161/strokeaha.113.002880 · Cited by 196
Intravenous Minocycline in Acute Stroke: A Randomized, Controlled Pilot Study and Meta-analysis
Kohler, E., Prentice, D. A., Bates, T. R., Hankey, G. J., Claxton, A., van Heerden, J., & Blacker, D. (2013) · Stroke · doi:10.1161/strokeaha.113.000780 · Cited by 164
Human cerebral infarct: a proposed histopathologic classification based on 137 cases
Mena, H., Cadavid, D., & Rushing, E. J. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0918-z · Cited by 156
How to make better use of thrombolytic therapy in acute ischemic stroke
Donnan, G., Davis, S., Parsons, M., Ma, H., Dewey, H., & Howells, D. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.89 · Cited by 151
Cannon, R. E., Peart, J. C., Hawkins, B. T., Campos, C. R., & Miller, D. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203534109 · Cited by 146
Czech-Zechmeister, B., Pfeilschifter, W., Mazaheri-Omrani, N., Strobel, M. A., Kahles, T., Neumann‐Haefelin, T., Rami, A., Huwiler, A., & Pfeilschifter, J. M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.142 · Cited by 145
Fingolimod and Sphingosine-1-Phosphate — Modifiers of Lymphocyte Migration
Maßberg, S., & von Andrian, U. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068159 · Cited by 129
Wacker, B. K., Park, T. S., & Gidday, J. M. (2009) · Stroke · doi:10.1161/strokeaha.109.560714 · Cited by 120
Liesz, A., Sun, L., Zhou, W., Schwarting, S., Mracsko, E. Z., Zorn, M., Bauer, H., Sommer, C., & Veltkamp, R. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021312 · Cited by 111
Establishing Final Infarct Volume
Gaudinski, M. R., Henning, E. C., Miracle, A. C., et al. (2008) · Stroke · doi:10.1161/strokeaha.107.512269 · Cited by 100
Inflammation After Stroke: Mechanisms and Therapeutic Approaches
Ahmad, M., & Graham, S. H. (2010) · Translational Stroke Research · doi:10.1007/s12975-010-0023-7 · Cited by 96
Campos, F., Qin, T., Castillo, J., Seo, J. H., Arai, K., Lo, E. H., & Waeber, C. (2013) · Stroke · doi:10.1161/strokeaha.112.679043 · Cited by 92
Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia
Pfeilschifter, W., Czech-Zechmeister, B., Sujak, M., Mirceska, A., Koch, A. H., Rami, A., Steinmetz, H., Foerch, C., Huwiler, A., & Pfeilschifter, J. M. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.070 · Cited by 78
Advances and challenges in treatment and prevention of ischemic stroke
Grossman, A. W., & Broderick, J. P. (2013) · Annals of Neurology · doi:10.1002/ana.23993 · Cited by 61
Brunkhorst, R., Kanaan, N., Koch, A. H., Ferreirós, N., Mirceska, A., Zeiner, P. S., Mittelbronn, M. G. A., Derouiche, A., Steinmetz, H., Foerch, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070124 · Cited by 53
Pfeilschifter, W., Czech-Zechmeister, B., Sujak, M., Foerch, C., Wichelhaus, T. A., & Pfeilschifter, J. M. (2011) · Experimental & Translational Stroke Medicine · doi:10.1186/2040-7378-3-2 · Cited by 41
Liu, H.-S., Chung, H., Chou, M., Liou, M., Wang, C.-Y., Kao, H., Chiang, S.-W., Juan, C., Huang, G.-S., & Chen, C. (2013) · Stroke · doi:10.1161/strokeaha.113.001558 · Cited by 33
Cited by
Chamorro, Á., Dirnagl, U., Urra, X., & Planas, A. M. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00114-9 · Cited by 1,198
Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities
Candelario-Jalil, E., Dijkhuizen, R. M., & Magnus, T. (2022) · Stroke · doi:10.1161/strokeaha.122.036946 · Cited by 953
Global brain inflammation in stroke
Shi, K., Tian, D.-C., Li, Z.-G., Ducruet, A. F., Lawton, M. T., & Shi, F.-D. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30078-x · Cited by 911
Self-citationImmune responses to stroke: mechanisms, modulation, and therapeutic potential.
Iadecola, C., Buckwalter, M. S., & Anrather, J. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135530 · Cited by 853
Microbiota Dysbiosis Controls the Neuroinflammatory Response after Stroke
Singh, V., Roth, S., Llovera, G., Sadler, R., Garzetti, D., Stecher, B., Dichgans, M., & Liesz, A. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1114-16.2016 · Cited by 794
Metadata
- Authors
- Fu, Y., Zhang, N., Ren, L., Yan, Y., Sun, N., Li, Y.-J., Han, W., Xue, R., Liu, Q., Hao, J., Yu, C., & Shi, F.-D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2014-12-08
- Volume
- 111
- Issue
- 51
- Pages
- 18315-18320
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2069634387
- Cited by
- 288
- References
- 42
- FWCI
- 12.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.